These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1684634)

  • 1. Effect of intranigral Mn2+ on striatal and nigral synthesis and levels of dopamine and cofactor.
    Daniels AJ; Abarca J
    Neurotoxicol Teratol; 1991; 13(5):483-7. PubMed ID: 1684634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis.
    Levine RA; Miller LP; Lovenberg W
    Science; 1981 Nov; 214(4523):919-21. PubMed ID: 6117945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat striatal dopamine and tetrahydrobiopterin content following an intrastriatal injection of manganese chloride.
    Lista A; Abarca J; Ramos C; Daniels AJ
    Life Sci; 1986 Jun; 38(23):2121-7. PubMed ID: 3713441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of manganese from the rat substantia nigra following intra-nigral microinjections.
    Ponzoni S; Gaziri LC; Britto LR; Barreto WJ; Blum D
    Neurosci Lett; 2002 Aug; 328(2):170-4. PubMed ID: 12133581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
    Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus.
    Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB
    J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system.
    Koshimura I; Imai H; Hidano T; Endo K; Mochizuki H; Kondo T; Mizuno Y
    Brain Res; 1997 Oct; 773(1-2):108-16. PubMed ID: 9409711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
    Kogan FJ; Nichols WK; Gibb JW
    Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the unilateral striatal lesion on neurotransmitter markers in the contralateral striatum and both substantia nigrae of the rat.
    Masuo Y; Kanazawa I
    Neuroscience; 1988 Dec; 27(3):827-36. PubMed ID: 2908058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine in manganese neurotoxicity.
    Parenti M; Rusconi L; Cappabianca V; Parati EA; Groppetti A
    Brain Res; 1988 Nov; 473(2):236-40. PubMed ID: 2852985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kainic acid lesion-induced nigral neuronal death.
    Foster JA; Bezin L; Groc L; Christopherson PL; Levine RA
    J Chem Neuroanat; 2003 Aug; 26(1):65-73. PubMed ID: 12954531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2007; (72):113-20. PubMed ID: 17982884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: an in vivo model relevant to Parkinson's disease.
    Kim SW; Jang YJ; Chang JW; Hwang O
    Neurobiol Dis; 2003 Jul; 13(2):167-76. PubMed ID: 12828940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.
    Opacka-Juffry J; Ashworth S; Sullivan AM; Banati RB; Blunt SB
    J Neural Transm (Vienna); 1996; 103(12):1429-34. PubMed ID: 9029409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).
    Neafsey EJ; Drucker G; Raikoff K; Collins MA
    Neurosci Lett; 1989 Nov; 105(3):344-9. PubMed ID: 2594220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.